Detailed price information for Praxis Precision Medicines Inc (PRAX-Q) from The Globe and Mail including charting and trades.

BOSTON, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system (CNS) ...

Detailed price information for Praxis Precision Medicines Inc (PRAX-Q) from The Globe and Mail including charting and trades.

Rapport Therapeutics, Inc. (NASDAQ:RAPP) stock traded higher on Monday, with a session volume of 3.20 million compared to the ...

What if you could build a personalized, AI-powered study assistant in just 10 minutes? Imagine having a tool that doesn’t just answer your questions but actively challenges you, adapts to your ...

US companies have invested between $35 billion and $40 billion in generative AI (genAI) projects, but most efforts are stuck in the pilot stage, according to a report from MIT’s NANDA initiative. Only ...

As a larger portion of Americans speak multiple languages than ever before, there is an alarming decrease in multilingual ...

PITTSBURGH--(BUSINESS WIRE)--PPG (NYSE:PPG) today announced the results of tests carried out in collaboration with HOYA Vision Care to compare the performance of PPG TRIVEX® lens material to ...

Funding is available from ARPA-E for magnet materials and rare earth element analysis. The application process starts now, and final selections come in January. The programs’ emphasis is on improving ...